NCT04396327View on ClinicalTrials.gov

SM-1 vs. an Active Comparator in A Model of Transient Insomnia

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 27, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Transient Insomnia
Interventions
DRUG

SM-1

diphenhydramine, zolpidem and lorazepam

DRUG

Active Comparator

diphenhydramine and lorazepam

Trial Locations (1)

10019

Clinilabs Drug Development Corporation, New York

All Listed Sponsors
lead

Sequential Medicine Ltd

INDUSTRY